StockData
Glucotrack, Inc. logo

Glucotrack, Inc. (GCTK) stock

GCTKOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.68−0.04 (-5.56%)

Close on Oct 19, 2026Market cap $3.43MP/E 0.0Yield –

Glucotrack r&d expenses

Research and development expenses are spending on new products and technology.

Glucotrack's R&D Expenses for the twelve months ending Jun 30, 2026 was $8.94M, up 1.8% year over year. For fiscal 2025 it was $9.81M, up 3.3% from the year before. Over ten years it grew 15.8% a year on average. The highest annual figure on record is $9.81M in fiscal 2025.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$9.81M+3.3%
FY2024Dec 31, 2024$9.50M+101.9%
FY2023Dec 31, 2023$4.70M+139.1%
FY2022Dec 31, 2022$1.97M+8.7%
FY2021Dec 31, 2021$1.81M+18.1%
FY2020Dec 31, 2020$1.53M-4.6%
FY2019Dec 31, 2019$1.61M-47.0%
FY2018Dec 31, 2018$3.03M-5.4%
FY2017Dec 31, 2017$3.21M+11.3%
FY2016Dec 31, 2016$2.88M+27.0%
FY2015Dec 31, 2015$2.27M+22.6%
FY2014Dec 31, 2014$1.85M-6.9%
FY2013Dec 31, 2013$1.99M+3.4%
FY2012Dec 31, 2012$1.92M+7.3%
FY2011Dec 31, 2011$1.79M+91.6%
FY2010Dec 31, 2010$934.06K-7.1%
FY2009Dec 31, 2009$1.01M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.02M-36.0%
Q1 FY2026Mar 31, 2026$2.13M+13.9%
Q4 FY2025Dec 31, 2025$1.63M-4.2%
Q3 FY2025Sep 30, 2025$3.17M+53.4%
Q2 FY2025Jun 30, 2025$3.15M-12.2%
Q1 FY2025Mar 31, 2025$1.87M-12.9%
Q4 FY2024Dec 31, 2024$1.70M-2.5%
Q3 FY2024Sep 30, 2024$2.06M+21.9%
Q2 FY2024Jun 30, 2024$3.59M+472.4%
Q1 FY2024Mar 31, 2024$2.15M+234.6%
Q4 FY2023Dec 31, 2023$1.74M+188.4%
Q3 FY2023Sep 30, 2023$1.69M+290.1%
Q2 FY2023Jun 30, 2023$627.00K+33.7%
Q1 FY2023Mar 31, 2023$642.00K+39.6%
Q4 FY2022Dec 31, 2022$604.00K-17.6%
Q3 FY2022Sep 30, 2022$434.00K-2.9%
Q2 FY2022Jun 30, 2022$469.00K+46.1%
Q1 FY2022Mar 31, 2022$460.00K+48.9%
Q4 FY2021Dec 31, 2021$733.00K+177.7%
Q3 FY2021Sep 30, 2021$447.00K-6.1%
Q2 FY2021Jun 30, 2021$321.00K-15.3%
Q1 FY2021Mar 31, 2021$309.00K-25.2%
Q4 FY2020Dec 31, 2020$264.00K-34.4%
Q3 FY2020Sep 30, 2020$476.00K+26.1%
Q2 FY2020Jun 30, 2020$379.00K-5.5%
Q1 FY2020Mar 31, 2020$413.00K-2.9%
Q4 FY2019Dec 31, 2019$402.38K-66.9%
Q3 FY2019Sep 30, 2019$377.38K-29.3%
Q2 FY2019Jun 30, 2019$401.12K-42.0%
Q1 FY2019Mar 31, 2019$425.12K-28.3%
Q4 FY2018Dec 31, 2018$1.21M-11.6%
Q3 FY2018Sep 30, 2018$534.13K-15.9%
Q2 FY2018Jun 30, 2018$691.89K+12.2%
Q1 FY2018Mar 31, 2018$592.70K+1.9%
Q4 FY2017Dec 31, 2017$1.37M+109.7%
Q3 FY2017Sep 30, 2017$635.48K-8.6%
Q2 FY2017Jun 30, 2017$616.82K–
Q1 FY2017Mar 31, 2017$581.54K–
Q4 FY2016Dec 31, 2016$654.98K–
Q3 FY2016Sep 30, 2016$695.44K–

More Glucotrack figures

See a number that looks wrong?